Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Amortization of Deferred Charges (2016 - 2017)

Cross Country Healthcare (CCRN) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $75000.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Amortization of Deferred Charges fell 82.64% year-over-year to $75000.0, compared with a TTM value of $1.3 million through Jun 2017, down 32.24%, and an annual FY2019 reading of $461000.0, up 2.9% over the prior year.
  • Amortization of Deferred Charges was $75000.0 for Q2 2017 at Cross Country Healthcare, down from $354000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $481000.0 in Q3 2014 and bottomed at $52000.0 in Q2 2014.
  • Average Amortization of Deferred Charges over 5 years is $296666.7, with a median of $413000.0 recorded in 2016.
  • The sharpest move saw Amortization of Deferred Charges surged 803.85% in 2015, then crashed 82.64% in 2017.
  • Year by year, Amortization of Deferred Charges stood at $57000.0 in 2013, then soared by 731.58% to $474000.0 in 2014, then rose by 0.21% to $475000.0 in 2015, then decreased by 13.05% to $413000.0 in 2016, then plummeted by 81.84% to $75000.0 in 2017.
  • Business Quant data shows Amortization of Deferred Charges for CCRN at $75000.0 in Q2 2017, $354000.0 in Q1 2017, and $413000.0 in Q4 2016.